To systematically investigate the neuroprotective role of BAP31 in PD pathogenesis, we performed dual biomarker analysis using NeuN (a neuronal nuclear marker) and GFAP (an astrocytic marker). This evidence concerns the gene RBFOX3 and Parkinson disease.